C&EN Webinars
Produced by C&EN Webinars

Navigating the Unexpected: Creative Solutions for Early Pharmaceutical Development

DATE
September 22, 2026
TIME
8:00 a.m. PT | 11:00 a.m. ET | 4:00 p.m. UK

Overview

Moving a molecule from discovery through early clinical development is rarely a straight path. Development teams must navigate technical and operational hurdles, including scale-up challenges, evolving impurity profiles, formulation issues, unexpected toxicology findings and the constant pressure to meet critical development milestones and clinical timelines. As programs progress, even small setbacks can create significant delays and strain limited budgets, making it essential to have the experience and tools to troubleshoot issues quickly and practically.

Join Cambrex experts Cy Credille and T.J. Harper as they discuss the most common – and some uncommon – challenges encountered during early pharmaceutical development and share creative yet practical strategies for overcoming them. They will share real-world examples of how the team at Cambrex’s facility in Longmont, Colorado, has accelerated development for clients through collaboration to solve manufacturing, analytical and formulation challenges.

Key Learning Objectives:
  • How to handle the unexpected in early drug development with minimal impact to timelines, and how to move forward when complexity arises
  • Case studies from Longmont, Colorado, where the Cambrex team specializes in providing drug substance and drug product development services to support IND submissions
Who Should Attend:
  • R&D
  • CMC (Chemistry, Manufacturing, and Controls)
  • Process Development
  • Pharmaceutical Manufacturing

Sponsored by:
Cambrex logo

Speakers

Cy Credille
Group Leader, Process Chemistry R&D,
Cambrex
T.J. Harper
Director of Operations,
Cambrex
Alexandra Taylor
Contributing Editor,
ACS Media Group

Registration

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society and its sponsor via email. You understand that you can withdraw your consent at any time. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

© 2026 American Chemical Society, 1155 16th St NW, Washington, DC 20036, USA. View our Privacy Policy